Trial Profile
Movantik for Opioid-Related Esophageal Disorders
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 02 Jan 2019
Price :
$35
*
At a glance
- Drugs Naloxegol (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 20 Dec 2018 Status changed from recruiting to discontinued.
- 24 Apr 2017 Status changed from not yet recruiting to recruiting.
- 22 Dec 2016 New trial record